Towards early detection of Cancer
Project Title: Profiling of tumour derived microvesicles using an innovative multiplex microfluidic assay
(M3 PROFILER) .
We believe we can do an impact together
The M3 PROFILER project aims to synergise the advantages of microfluidics, and multiplex bead based assays, to measure biomarkers in blood-derived exosomes (vesicles that originate from solid tumours). The project is funded under the FUSION program administered by the Malta Council for Science and Technology (MCST).
JOIN US and SUBSCRIBE below for more information on other innovative products and applications.
Product Development and Projects
CoV-plex
To develop a molecular test that measures COVID-19 (SARS-CoV-2) immune response for vaccine surveillance.
iMPACT
Innovative molecular profiling assays to classify tumours. We developed multiplex assays for academic research and lab based testing programs.
Bookind
To innovate a companion diagnostic product that predicts use of specific therapeutics in Epilepsy.
